Return On Assets of Eledon Pharmaceuticals, Inc. from 30 Jun 2015 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Eledon Pharmaceuticals, Inc. quarterly and annual Return On Assets in % history and change rate from 30 Jun 2015 to 30 Sep 2025.
  • Eledon Pharmaceuticals, Inc. Return On Assets for the quarter ending 30 Sep 2025 was -52%, a 143% decline year-over-year.
  • Eledon Pharmaceuticals, Inc. annual Return On Assets for 2024 was -29%, a 76% increase from 2023.
  • Eledon Pharmaceuticals, Inc. annual Return On Assets for 2023 was -125%, a 98% decline from 2022.
  • Eledon Pharmaceuticals, Inc. annual Return On Assets for 2022 was -63%, a 230% decline from 2021.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Change (%)
Return On Assets, Annual (%)
Return On Assets, YoY Annual Change (%)

Eledon Pharmaceuticals, Inc. Quarterly Return On Assets (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2025 -52% -31% -143% 01 Jul 2025 30 Sep 2025
Q2 2025 10% +122% 01 Apr 2025 30 Jun 2025
Q1 2025 -13% +126% +90% 01 Jan 2025 31 Mar 2025
Q4 2024 -29% +95% +76% 01 Oct 2024 31 Dec 2024
Q3 2024 -21% +132% +86% 01 Jul 2024 30 Sep 2024
Q2 2024 -112% +22% +17% 01 Apr 2024 30 Jun 2024
Q1 2024 -139% -65% -87% 01 Jan 2024 31 Mar 2024
Q4 2023 -125% -62% -98% 01 Oct 2023 31 Dec 2023
Q3 2023 -153% -129% -535% 01 Jul 2023 30 Sep 2023
Q2 2023 -135% -112% -493% 01 Apr 2023 30 Jun 2023
Q1 2023 -74% -53% -258% 01 Jan 2023 31 Mar 2023
Q4 2022 -63% -44% -230% 01 Oct 2022 31 Dec 2022
Q3 2022 -24% -7% -43% 01 Jul 2022 30 Sep 2022
Q2 2022 -23% -8% -56% 01 Apr 2022 30 Jun 2022
Q1 2022 -21% -5% -32% 01 Jan 2022 31 Mar 2022
Q4 2021 -19% +3% +13% 01 Oct 2021 31 Dec 2021
Q3 2021 -17% +20% +54% 01 Jul 2021 30 Sep 2021
Q2 2021 -15% +127% +90% 01 Apr 2021 30 Jun 2021
Q1 2021 -16% +117% +88% 01 Jan 2021 31 Mar 2021
Q4 2020 -22% +89% +80% 01 Oct 2020 31 Dec 2020
Q3 2020 -37% +66% +64% 01 Jul 2020 30 Sep 2020
Q2 2020 -141% -42% -42% 01 Apr 2020 30 Jun 2020
Q1 2020 -133% -45% -51% 01 Jan 2020 31 Mar 2020
Q4 2019 -111% -45% -69% 01 Oct 2019 31 Dec 2019
Q3 2019 -103% -51% -99% 01 Jul 2019 30 Sep 2019
Q2 2019 -99% -52% -108% 01 Apr 2019 30 Jun 2019
Q1 2019 -88% -28% -46% 01 Jan 2019 31 Mar 2019
Q4 2018 -66% -11% -21% 01 Oct 2018 31 Dec 2018
Q3 2018 -52% +25% +33% 01 Jul 2018 30 Sep 2018
Q2 2018 -48% +13% +22% 01 Apr 2018 30 Jun 2018
Q1 2018 -60% -31% -104% 01 Jan 2018 31 Mar 2018
Q4 2017 -54% -3% -6.3% 01 Oct 2017 31 Dec 2017
Q3 2017 -77% -28% -57% 01 Jul 2017 30 Sep 2017
Q2 2017 -61% -5% -8% 01 Apr 2017 30 Jun 2017
Q1 2017 -29% +30% +50% 01 Jan 2017 31 Mar 2017
Q4 2016 -51% +4% +6.6% 01 Oct 2016 31 Dec 2016
Q3 2016 -49% -5% -12% 01 Jul 2016 30 Sep 2016
Q2 2016 -56% -22% -62% 01 Apr 2016 30 Jun 2016
Q1 2016 -60% 01 Jan 2016 31 Mar 2016
Q4 2015 -55% 01 Oct 2015 31 Dec 2015
Q3 2015 -44% 01 Jul 2015 30 Sep 2015
Q2 2015 -35% 01 Apr 2015 30 Jun 2015

Eledon Pharmaceuticals, Inc. Annual Return On Assets (%)

Period Value YoY Chg Change % Start Date End Date
2024 -29% +95% +76% 01 Jan 2024 31 Dec 2024
2023 -125% -62% -98% 01 Jan 2023 31 Dec 2023
2022 -63% -44% -230% 01 Jan 2022 31 Dec 2022
2021 -19% +3% +13% 01 Jan 2021 31 Dec 2021
2020 -22% +89% +80% 01 Jan 2020 31 Dec 2020
2019 -111% -45% -69% 01 Jan 2019 31 Dec 2019
2018 -66% -11% -21% 01 Jan 2018 31 Dec 2018
2017 -54% -38% -242% 01 Jan 2017 31 Dec 2017
2016 -16% +39% +71% 01 Jan 2016 31 Dec 2016
2015 -55% 01 Jan 2015 31 Dec 2015
* An asterisk sign (*) next to the value indicates that the value is likely invalid.